SEC Form 4 · accession 0001679039-26-000003
LeonaBio, Inc. · LONA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael A. Panzara
Director
Period of report
Jun 23, 2026
Accepted (ET)
Jun 24, 2026 · 6:33 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001620463
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $8.35 | Jun 23, 2026 | A | 28,000 | A | — | Jun 22, 2036 | Common Stock | 28,000 | 28,000 | D |
Explanation of responses
- F1The shares subject to the option will vest on the earlier of (i) June 23, 2027, or (ii) the day immediately before the date of the next annual meeting of the Issuer's stockholders that occurs after June 22, 2026. The option reported was granted pursuant to the terms of the Issuer's Outside Director Compensation Policy.